Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006). - Li, Grace; Marchevsky, Natalie G.; Macaulay, Grace; Aley, Parvinder; Baughan, Hannah; Plested, Emma; Bibi, Sagida; Cappuccini, Federica; Faust, Saul N.; Heath, Paul T.; Muller, Jill; Robinson, Hannah; et al. (Vaccine, 2025)